Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where GoodRx is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13D/A2026-08-26SCHEDULE 13D/A
- 8-K2026-08-05Current report (material event)
- 10-Q2026-08-05Quarterly report
- 8-K2026-08-05Current report (material event)
- 8-K2026-06-18Current report (material event)
- 10-Q2026-05-06Quarterly report
- 8-K2026-05-06Current report (material event)
- ARS2026-04-29Annual report to holders
- DEFA14A2026-04-29DEFA14A
- DEF 14A2026-04-29Proxy statement
- 8-K2026-04-24Current report (material event)
- 8-K2026-04-03Current report (material event)
- 8-K2026-03-27Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K2026-03-18Current report (material event)
- 8-K2026-03-06Current report (material event)
- 8-K2026-02-27Current report (material event)
- S-82026-02-26Employee stock plan
- 10-K2026-02-26Annual report
- 8-K2026-02-25Current report (material event)
- 8-K2025-12-12Current report (material event)
- 10-Q2025-11-04Quarterly report
- 8-K2025-11-04Current report (material event)
- 8-K2025-11-03Current report (material event)
- SCHEDULE 13G/A2025-10-30SCHEDULE 13G/A
- SCHEDULE 13D/A2025-10-16SCHEDULE 13D/A
- SCHEDULE 13D/A2025-09-08SCHEDULE 13D/A
- 10-Q2025-08-06Quarterly report
- 8-K2025-08-06Current report (material event)
- SCHEDULE 13D/A2025-07-03SCHEDULE 13D/A
- SCHEDULE 13D/A2025-06-09SCHEDULE 13D/A
- 8-K2025-06-04Current report (material event)
- SCHEDULE 13G/A2025-05-15SCHEDULE 13G/A
- SCHEDULE 13G/A2025-05-14SCHEDULE 13G/A
- 10-Q2025-05-07Quarterly report
- 8-K2025-05-07Current report (material event)
- ARS2025-04-23Annual report to holders
- DEFA14A2025-04-23DEFA14A
- DEF 14A2025-04-23Proxy statement
- SCHEDULE 13D/A2025-03-21SCHEDULE 13D/A
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.